MetrionAIIntelligence

Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

ProSomnus, Inc.

OSA

HealthcareNASDAQUS

$0.47

$0.00 (+0.00%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

OSA

1Y0 (0.00%)

Candles, volume, SMA 20, and SMA 50

O 0.5H 0.47L 0.47C 0.47Date Jun 17

OSA

SMA 20 SMA 50 Vol 58.85KEEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

ProSomnus, Inc. manufactures precision oral appliance therapy devices for the treatment of obstructive sleep apnea (OSA). The company was founded in 2016 and is based in Pleasanton, California.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$8.18M

Volume?58.85K

Avg Volume?58.85K

52w Range$0.47 - $0.50

Beta?0.21

Price Performance

0.0%

$0.47 to $0.47

YTD

0.0%

$0.47 to $0.47

0.0%

$0.47 to $0.47

-90.4%

$4.90 to $0.47

N/A

history unavailable

10Y

N/A

history unavailable

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide

CEOLeonard Liptak

IndustryMedical - Devices

Employees136

IPO Date2021-07-28

CurrencyUSD

Websitewww.ProSomnus.com

Related stocks

Check out other names from the same Medical - Devices industry as OSA.

BIOR-

Biora Therapeutics, Inc.

COSCIENS Biopharma Inc.

2.72USD

N/A

NLTX-

Neoleukin Therapeutics, Inc.

Holdco Nuvo Group D.G Ltd. Ordinary Shares

0.17USD

N/A

OMGA-

Omega Therapeutics, Inc.

0.14USD

N/A

SSY-

SunLink Health Systems, Inc.

1.12USD

N/A

TSBX-

Turnstone Biologics Corp.

0.36USD

N/A

TVRD-

Tvardi Therapeutics, Inc.

2.89USD

N/A